AZD-5312

N/A

Report date: 2023/11/07 20:06:51

Base Information

Drug NameAZD-5312
Drug Alias NameISIS- 560131ISIS-AZ1RxAZD-5312IONIS-AR-2.5Rx
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionAndrogen Receptor antagonists
TargetsAndrogen Receptor
Therapy Area/IndicationsProstatic Neoplasms, Castration-ResistantProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesIonis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRuibo (Hong Kong) Biotechnology Co LtdSuzhou Ruibo Biotechnology Co LtdUniversity Of Michigan Rogel Cancer Center +[6] 
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms, Castration-ResistantProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A